dr reddy semaglutide Biosimilars could surpass generics in US mkt by early 2030s: Reddy's CEO | People Dr Reddy's pauses weight loss

Here's what I, as a physician, see in the current scientific landscape

Barberine has been shown to have numerous positive effects such as decreasing cholesterol levels and reducing weight and adipose tissue in obese mice

GLP-1 and GIP receptor activation produces gastrointestinal effects (nausea, reduced appetite) that are dose-dependent

Engage in light physical activity to avoid bloating

Still, this mechanism was discovered in the 1980s - it took us 40 years to get here

All these studies indicate that injection lipolysis may be an effective option for reducing small to medium fat deposits in areas resistant to diet and exercise